GO
Loading...

Valeant Pharmaceuticals International Inc

More

  • BOSTON/ NEW YORK, Oct 1- Prominent investor shareholder advisory firm ISS called on Allergan Inc to give its shareholders a chance to vote on any large, buyout-blocking acquisitions and said the company's board faced a credibility problem, according to a report seen by Reuters.

  • Sept 26- T. Rowe Price, the second largest shareholder in Allergan Inc, said on Friday that it wants the company to hold off on making major moves before a Dec. 18 special shareholder meeting, and criticized the board's corporate governance.

  • Business Highlights Thursday, 25 Sep 2014 | 5:59 PM ET

    Prices at the pump head below $3 in much of US. The average in Springfield, Missouri, is already below $3, according to Tom Kloza, chief oil analyst at the Oil Price Information Service and GasBuddy.com. The gap is 20 cents or more in seven states, including California, Kansas, South Dakota and Connecticut, according to AAA.

  • Skechers and Apple are big market movers Thursday, 25 Sep 2014 | 4:24 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:. Skechers USA Inc., up $1.65 to $54.05. BP PLC, down $1.45 to $44.06.

  • Sept 25- Hedge fund ValueAct Capital said on Thursday it would return to the board of directors of Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for Allergan Inc, and that it planned to increase its stake in the company.

  • NYSE stocks posting largest percentage increases Thursday, 25 Sep 2014 | 1:24 PM ET

    NEW YORK— A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:. Imprivata Inc. rose 12.4 percent to $14.94. Magnum Hunter Resources Corp. rose 9.9 percent to $6.00.

  • Valeant pitches potential eye drug, research focus Thursday, 25 Sep 2014 | 8:28 AM ET

    Valeant Pharmaceuticals is drawing attention to a potential glaucoma treatment and its focus on product development, as the Canadian drugmaker continues to build its case to investors for a takeover of Botox-maker Allergan.

  • Acorda and GrafTech are big market movers Wednesday, 24 Sep 2014 | 4:49 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:. GrafTech International Ltd., down $2.23 to $4.96. Green Dot Corp., up $4.59 to $23.41.

  • NYSE stocks posting largest percentage increases Wednesday, 24 Sep 2014 | 1:21 PM ET

    NEW YORK— A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:. Green Dot Corp. rose 24.4 percent to $23.41. WageWorks Inc. rose 7.9 percent to $49.90.

  • Valeant Pharma expects 3Q revenue to top forecasts Wednesday, 24 Sep 2014 | 11:59 AM ET

    Allergan has rebuffed several takeover bids from Valeant over the past few months, the latest amounting to about $53 billion. That could give Valeant and activist investor Bill Ackman's Pershing Square Capital Management LP, which has built a large stake in Allergan, a chance at a takeover.

  • Since Valeant and Pershing Square offered to buy Allergan on April 22, Allergan has consistently rejected their offer, saying it undervalues the company. "We believe Valeant and Pershing Square are conducting a fishing expedition for their own purposes and contrary to the best interests of Allergan stockholders," Allergan's spokesman said on Monday.

  • Sept 22- A U.S. court ordered drugmaker Allergan Inc to produce board documents related to its strategy to counter the hostile bid by William Ackman's Pershing Square Capital Management and Canada's Valeant Pharmaceuticals International.

  • NEW YORK, Sept 16- Some of the top 20 investors at Salix Pharmaceuticals Ltd are threatening to vote down a proposed deal to buy a unit of Cosmo Pharmaceuticals SpA, and are pressing Salix to consider selling itself instead, people familiar with the matter said on Tuesday.

  • Early movers: HSY, SHLD, BX, BA, LMNT, BABA & more Tuesday, 16 Sep 2014 | 7:35 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Sept 16- Allergan Inc and its suitors Pershing Square Capital Management and Valeant Pharmaceuticals Inc settled their pending litigation before the Delaware Court of Chancery and agreed to hold a special shareholder meeting on the originally scheduled date, Dec. 18.

  • Ackman plans Amsterdam fund IPO in Europe push Monday, 15 Sep 2014 | 4:30 AM ET

    Bill Ackman has announced plans to float a fund on the Amsterdam Stock Exchange, with the hope of raising at least $5 billion.

  • Midday movers: eBay, Sprint, Yahoo & more Friday, 12 Sep 2014 | 12:20 PM ET

    Take a look at some of Friday's midday movers:

  • Early movers: AAPL, TWTR, FDO, DG, MSFT, LE & more Wednesday, 10 Sep 2014 | 7:40 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Ackman to Allergan board: 'Wake up' on Valeant talks Wednesday, 10 Sep 2014 | 6:21 AM ET
    William 'Bill' Ackman, founder and chief executive officer of Pershing Square Capital Management LP, speaks during an event in New York, U.S.

    William Ackman criticized Allergan's board of directors, urging them to "wake up" and at least listen to potential purchaser Valeant Pharmaceuticals.

  • BOSTON, Sept 9- After months of staying largely silent on a deal he is trying to broker, billionaire William Ackman on Tuesday criticized Allergan Inc' s board of directors, urging them to "wake up" and at least listen to what potential purchaser Valeant Pharmaceuticals has to offer the Botox maker.